Video

Glaucoma 360: Science fiction or science fact in eye care

Author(s):

Sheryl Stevenson
Conferences|GLAUCOMA 360

Ranya Habash, MD, medical director of Technology Innovation, assistant professor of Clinical Ophthalmology at Bascom Palmer Eye Institute, University of Miami in Miami, Florida, offers a preview of her New Horizons keynote speech on "The future of eye care: science fiction to science fact."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
Related Content
(Image credit: AdobeStock/RFBSIP) The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucoma
June 4th 2025

The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucoma

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Q&A: Rachel Downes, MD, provides highlights from the GATHER1 and GATHER2 clinical trials for GA
June 2nd 2025

Q&A: Rachel Downes, MD, provides highlights from the GATHER1 and GATHER2 clinical trials for GA

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Q&A: Sharon Fekrat, MD, FACS, FASRS, on the value of scientific meetings and collaboration
May 31st 2025

Q&A: Sharon Fekrat, MD, FACS, FASRS, on the value of scientific meetings and collaboration

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis
May 30th 2025

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis

© 2025 MJH Life Sciences

All rights reserved.